LSA
PCVX icon

Leonteq Securities AG’s Vaxcyte PCVX Stock Holding History

Leonteq Securities AG’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-110
Closed -$6.39K – 1357
2026
Q1 		$6.39K Sell
110
-5,376
-98% -$292K ﹤0.01% 1098
2025
Q4 		$253K Sell
5,486
-1,275
-19% -$57K 0.01% 615
2025
Q3 		$244K Buy
6,761
+566
+9% +$18.8K 0.01% 565
2025
Q2 		$201K Sell
6,195
-2,237
-27% -$73.3K 0.01% 568
2025
Q1 		$316K Buy
8,432
+6,993
+486% +$559K 0.02% 455
2024
Q4 		$123K Buy
1,439
+1,276
+783% +$127K 0.01% 643
2024
Q3 		$18.6K Sell
163
-295
-64% -$26.6K ﹤0.01% 917
2024
Q2 		$34.6K Sell
458
-79
-15% -$5.38K ﹤0.01% 834
2024
Q1 		$36.7K Buy
+537
New +$37.2K ﹤0.01% 825

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Leonteq Securities AG's PCVX Position: Q2 2026 in Review

Leonteq Securities AG sold out of Vaxcyte (PCVX) in Q2 2026, closing a stake of 110 shares — an estimated $6.39K sold.

Leonteq Securities AG first reported a position in PCVX in Q1 2024 and held it in 9 quarters. The position peaked at $316K in Q1 2025. 330 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

  • Leonteq Securities AG reported no remaining Vaxcyte position as of Q2 2026 after selling out during the quarter.
  • Leonteq Securities AG sold 110 Vaxcyte shares in Q2 2026, an estimated $6.39K.
  • Leonteq Securities AG first reported a position in Vaxcyte in Q1 2024 and held it in 9 quarters.
  • Leonteq Securities AG's Vaxcyte position peaked at $316K in Q1 2025.
  • 330 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on Leonteq Securities AG's 13F filing for Q2 2026, filed 27 Jul 2026.